The Bright Future of Cancer Immunotherapy: DNA Vaccines on the Front Lines of Lung Cancer

Article Type:
Review Article (بدون رتبه معتبر)

The advancements in immuno-oncology have created a new and unparalleled opportunity for the advancement of vaccination methods. Therapeutic DNA cancer vaccines are now regarded as an excellent way to stimulate the immune system in its fight against cancer. Lung cancer is well recognized as one of the primary factors leading to patient mortality worldwide. Despite significant advancements in innovative tumor immunotherapy, including the use of immune checkpoint inhibitors or oncolytic viruses, the overall 5-year survival rate of individuals with lung malignancies remains very low. Therefore, there is an urgent need to find efficacious vaccinations for the treatment of lung cancer. DNA vaccines are now regarded as a viable immunotherapy approach to stimulate the host immune system against lung cancer. First, we discuss antigen repertoire selection and delivery strategies to improve cancer vaccines. We summarize the recent advances in DNA vaccines that target lung cancer antigens and highlight their implications for disease treatment.

Advanced Therapies Journal, Volume:6 Issue: 18, 2024
10 to 17  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!